华恒生物 (688639.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(华恒生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 522,813,388.64515,439,364.12500,781,373.59574,106,855.72514,272,654.57449,633,853.69400,254,753.80
 营业收入(元) 522,813,388.64515,439,364.12500,781,373.59574,106,855.72514,272,654.57449,633,853.69400,254,753.80
二、营业总成本(元) 512,110,419.43458,905,830.01411,603,470.89440,899,605.90377,595,006.76318,257,776.01310,953,639.35
 营业成本(元) 410,952,885.67362,488,488.47332,636,926.09352,100,108.30306,760,239.51249,281,322.44244,814,225.07
 研发费用(元) 27,162,038.2234,867,920.6428,484,280.2031,510,994.2522,962,262.5729,624,968.5624,726,169.10
 营业税金及附加(元) 3,635,999.683,198,918.522,655,950.842,553,524.262,723,930.982,462,207.623,004,350.78
 销售费用(元) 15,396,995.3920,699,171.9310,871,898.7815,204,065.8711,286,156.9916,215,651.027,697,747.71
 管理费用(元) 43,236,737.4834,552,984.3532,352,137.0832,985,432.3232,100,993.8329,297,175.1927,297,615.30
 财务费用(元) 11,725,762.993,098,346.104,602,277.906,545,480.901,761,422.88-8,623,548.823,413,531.39
  其中:利息费用(元) 10,530,705.089,146,490.647,443,732.595,229,448.263,274,563.971,244,481.32889,725.79
  其中:利息收入(元) 655,507.071,414,997.05665,131.47568,596.97803,005.341,124,208.02552,206.92
 信用减值损失(元) -49,433.17-684,117.541,205,714.07597,820.791,038,041.48-1,096,331.69-942,976.05
三、其他经营收益
 加:公允价值变动收益(元) ----3,698.63-33,287.67-504,741.73228,490.10
 加:投资收益(元) 1,094,191.69--82,682.25184,813.761,239,186.701,353,895.07
  其中:对联营企业和合营企业的投资收益(元) 1,094,191.69------
 资产处置收益(元) -4,935.14-38,252.71-28,746.0512,772.02---524,294.01
 其他收益(元) 7,323,108.6911,603,604.875,878,493.7911,216,576.274,218,679.123,127,116.112,582,371.78
四、营业利润(元) 19,065,901.2867,180,038.4696,233,364.51142,171,159.65142,067,898.30134,665,601.0891,998,601.34
 加:营业外收入(元) 1,151,879.06851,658.56358,340.42200,832.27810,105.80562,551.0818,160.19
 减:营业外支出(元) 600,672.61123,983.145,771.01-1,218,213.581,344,383.875,830,566.58267,230.64
五、利润总额(元) 19,617,107.7367,907,713.8896,585,933.92143,590,205.50141,533,620.23129,397,585.5891,749,530.89
 减:所得税费用(元) -387,499.005,784,205.5610,717,330.2716,389,534.7513,253,182.5119,467,225.0010,561,193.76
六、净利润(元) 20,004,606.7362,123,508.3285,868,603.65127,200,670.75128,280,437.72109,930,360.5881,188,337.13
(一)按经营持续性分类
  持续经营净利润(元) 20,004,606.7362,123,508.3285,868,603.65127,200,670.75128,280,437.72109,930,360.5881,188,337.13
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 20,185,971.9963,133,620.7286,574,111.12129,112,270.68128,712,551.61110,038,359.1981,198,285.24
  少数股东损益(元) -181,365.26-1,010,112.40-705,507.47-1,911,599.93-432,113.89-107,998.61-9,948.11
 扣除非经常性损益后的净利润(元) 18,128,594.1561,592,995.7785,910,725.23123,119,372.54125,519,890.78111,137,440.0978,316,720.65
七、每股收益
 一、基本每股收益(元) -0.210.400.550.810.810.470.75
 二、稀释每股收益(元) -0.210.400.550.810.810.470.75
八、其他综合收益(元) -285,167.3965,853.9223,061.82----
 归属于母公司股东的其他综合收益(元) -285,167.3965,853.9223,061.82----
九、综合收益总额(元) 19,719,439.3462,189,362.2485,891,665.47127,282,396.29128,280,437.72109,930,360.5881,188,337.13
 归属于母公司所有者的综合收益总额(元) 19,900,804.6063,199,474.6486,597,172.94129,193,996.22128,712,551.61110,038,359.1981,198,285.24
 归属于少数股东的综合收益总额(元) -181,365.26-1,010,112.40-705,507.47-1,911,599.93-432,113.89-107,998.61-9,948.11
公告日期 2024-10-292024-08-282024-04-222024-04-222023-10-262023-08-292023-04-26
审计意见(境内) 标准无保留意见

前瞻产业研究院